Artal Group’s Achilles Therapeutics plc American Depositary Shares ACHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-755,375
| Closed | -$616K | – | 104 |
|
|
2024
Q2 | $616K | Hold |
755,375
| – | – | 0.02% | 97 |
|
|
2024
Q1 | $944K | Sell |
755,375
-1,500,000
| -67% | -$1.88M | 0.02% | 92 |
|
|
2023
Q4 | $2.01M | Hold |
2,255,375
| – | – | 0.07% | 60 |
|
|
2023
Q3 | $2.05M | Hold |
2,255,375
| – | – | 0.09% | 65 |
|
|
2023
Q2 | $2.13M | Hold |
2,255,375
| – | – | 0.07% | 79 |
|
|
2023
Q1 | $2.16M | Hold |
2,255,375
| – | – | 0.13% | 79 |
|
|
2022
Q4 | $2.03M | Hold |
2,255,375
| – | – | 0.11% | 85 |
|
|
2022
Q3 | $5.1M | Hold |
2,255,375
| – | – | 0.22% | 56 |
|
|
2022
Q2 | $5.68M | Hold |
2,255,375
| – | – | 0.3% | 51 |
|
|
2022
Q1 | $6.63M | Hold |
2,255,375
| – | – | 0.28% | 67 |
|
|
2021
Q4 | $11.3M | Hold |
2,255,375
| – | – | 0.31% | 61 |
|
|
2021
Q3 | $17.6M | Hold |
2,255,375
| – | – | 0.39% | 55 |
|
|
2021
Q2 | $22.1M | Hold |
2,255,375
| – | – | 0.45% | 42 |
|
|
2021
Q1 | $37.3M | Buy |
+2,255,375
| New | +$37.3M | 0.66% | 28 |
|